Persistence Market Research Blog

A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it may cause in the anal canal. This type of cancer is usually associated with human papiloma virus (HPV), where HPV cancers or cervical cancers have a high risk of developing into anal cancer. There are no exact symptoms for anal cancer as such but some might show bleeding from the anal area, lump or swelling near anus or change in the bowel habits etc.  Staging is a way which describes the location of cancer, the stages include tumor, node and metastasis which is further grouped I, II, IIIA, IIIB and IV. The different types of anal cancer include melanoma, adenocarcinoma, basaloid transitional and cloacogenic cancer.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/10658

The statistics for anal cancer suggest that annually there about 6000 cases of anal cancer diagnosed in the U.S. and the number is increasing slowly. The major factors that drive the market for anal cancer therapeutics are aging population, sexually transmitted disease, multiple sexual partners and smoking. According to the World Health Organization 290 million women are suffering from HPV infection and due to unhealthy sex, the chances get doubled. For treating this anal cancer, early diagnosis is crucial which is only available in the developed countries or high-income countries and are accessible. Whereas in the low-income countries the diagnosis and treatment facilities are either costly or inaccessible. These factors are responsible for holding back the anal cancer therapeutics market and should be well tracked for future advancements.

The anal cancer therapeutics market can be classified on the basis of product type and distribution channel.

According to the product type, the anal cancer therapeutics can be sun-divided into the following:

  • Chemotherapy drugs
    • Fluorouracil
    • Cisplatin
    • Carboplatin

According to the distribution channel, the anal cancer therapeutics can be sun-divided into the following:

  • Hospitals
  • Long-term care centers
  • Pharmacies
  • Diagnostic Laboratories

Altogether 80% of anal cancers are developed after the age of 60 and the ones which occur prior to age 35 are mostly observed in men. Almost half of the anal caners are diagnosed before the cancer turns to be malignant but when the cancer is found through early diagnosis are treatable. The survival rate of anal cancer in male is 60% and 70% in female for 5 years. Most of the anal cancers are treated with combination therapy and some are treated with surgery when early diagnosed. Cancer treatment includes chemotherapy, radiation therapy and surgery which is also dependent on the stage of the tumor.

Worldwide there are 1 or 2 cases per 100000 cases and accounts for about 1.5 % of the cases in the United States. Anal cancer therapeutics market share is more in North America followed by Europe. In U.K the incidence cases did not grow in the past few years and thus the anal cancer accounts for less than 1% of all the deaths. In the developed countries and developing countries several epidemiologic studies have found out that the chances for developing anal cancer can be directly related to sexual practices. Also the number of the sexually transmitted diseases has increased over the past couple of years leading to rise in the number of diseases and infections. The developed countries have proper healthcare facilities and thus treatment for anal cancer is possible.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/10658

The major market players in the anal cancer therapeutics are GlaxoSmithKline Pharmaceuticals Ltd., Spectrum Pharmaceuticals, Inc., Hospira, Inc., Global BioPharma, Inc., and Advaxis, Inc.

The report covers exhaustive analysis on:

  • Anal Cancer Therapeutics Market Segments
  • Anal Cancer Therapeutics Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Anal Cancer Therapeutics Market Size & Forecast 2016 to 2022
  • Anal Cancer Therapeutics Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Anal Cancer Therapeutics Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Browse Full PDF: Anal Cancer Therapeutics Market

Construction aggregates are a broad category of granular materials such as crushed stone, stone, and gravel etc., which finds application in construction activities. Aggregates are the world’s most mined material. Aggregates give resistance to wear and erosion, volume stability, and other desired physical properties to the finished product. Read the rest of this entry »

Product portfolio management is a business lifecycle function in an organization that deals with the planning, forecasting, and production of a product or products at all stages of product lifecycle. It integrates people, data, process, and business systems.  PPM software helps enterprises/organization to improve their strategic planning and business execution. PPM software assists business organizations to accelerate the pace of innovation, improve productivity, and more effectively adapt to rapidly changing economic conditions and competitive dynamics.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/10637

Applications of Project Portfolio Management (PPM) Software:

  • Information Technology Solution
  • New Product Development Solution
  • Professional Services

In the current information technology world, business enterprises have increased their scale of operations by diversifying their variation in their product portfolio. In order to manage entire information: starting with the ideation to implementation of a product has become critical that led to the innovation of a new software named as a Project Portfolio management (PPM). Moreover, the functionality of products is increasing, making their development and support more complex. Therefore, necessity of making product development process smoother, across various industries has led to the introduction project portfolio management (PPM) software

However, cost and complexity issues attached with PPM software have been long standing hurdles to widespread PPM software adoption. In the various enterprises applications, PPM requires huge cost and has to experience complexity in the IT infrastructure. It spreads across variety of related applications, demands cross functional corporation, and requires a sizable investment in outside consultants in order to manage both the technical and organizational aspects of implementation.

Segmentation of project portfolio management market on the basis of deployment model:

  • On-Premises:

On-Premises project portfolio management (PPM) software are deployed and operates on the computers in the premises of the organization using the PPM software, rather than at remote facility including remote servers and cloud on internet.

  • Hosted : 

Hosted project portfolio management (PPM) software are provided by cloud service providers. Hosted environments reduces the cost associated with mobile enterprise application development platform.

North America region is fastest growing market in PPM software adoption. The demand for mechanical computer aided design (MCAD) and electronic computer aided design (ECAD), and other project specific software in countries such as the U.S. and Canada is driving the growth of the market.

PPM market in aerospace and defense sector in the Asia-Pacific region holds significant growth potential. Cloud based PPM software are also gaining popularity in countries such as China and Regulatory compliance, increased safety, enhanced design innovation, and product processes are cornerstones for the growth of advanced PPM software in Europe. Furthermore, intensifying concerns about safety and decreasing, maintenance expenditure will catalyze the PPM software market in Europe.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/10637

CA Technologies, Microsoft Corporation, Oracle Corporation, SAP SE, Workfront, Inc., and Planview are few of the leading players of global project portfolio management (PPM) software market.

The report covers exhaustive analysis on:

  • Project Portfolio Management (PPM) Market Segments
  • Project Portfolio Management (PPM) Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Project Portfolio Management (PPM) Market Size & Forecast 2016 to 2024
  • Project Portfolio Management (PPM) Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Project Portfolio Management (PPM) Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

 

Product life-cycle management (PLM) is an information system that can integrate data, processes, business systems, and eventually people in an extended enterprise. PLM software allows a company to manage information throughout entire lifecycle of product efficiently and cost-effectively. It includes processes from ideation, design and manufacture and disposal of the product. Read the rest of this entry »

Rheumatoid arthritis (RA) is an autoimmune disease that causes the body’s immune system to attack joint tissues, which leads to inflammation of joint lining. Such inflammation of joint lining causes pain, stiffness, swelling, warmth, and redness. Rheumatoid arthritis is most prevalent among women. RA can be diagnosed through two methods, namely X–ray imaging and blood tests/serology test.

View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/rheumatoid-arthritis-market.asp

Global rheumatoid arthritis diagnosis tests market has been estimated to be valued at US$ 485.5 Mn in 2015, and is anticipated to increase to US$ 738.7 Mn by 2022, registering a CAGR of 6.2% during the forecast period. Incidence of RA are increasing among children in Europe and North America. This increased incidence rate calls for adoption of minimally-invasive test methods to diagnose rheumatoid arthritis. Hence, there is high demand for RA test kits with minimally-invasive testing method in Europe and North America.

By test type, the global rheumatoid arthritis diagnosis tests market is segmented into serology test and RA treatment efficiency monitoring tests. Serology test segment is further sub-segmented into erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid test, and other tests. RA treatment efficiency monitoring tests segment is further sub-segmented into Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), and Creatinine Test.

By end user, the global rheumatoid arthritis diagnosis tests market is segmented into a hospital, diagnostic laboratories, and ambulatory surgical centers. Diagnostic laboratory segment is further sub-segmented into private laboratories and public laboratories.

By region, the global rheumatoid arthritis diagnosis tests market is segmented into North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. Europe and Asia Pacific regions have been estimated to account for 61% market share in 2015.

Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/4788

Key players operating in the Rheumatoid Arthritis market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.

Browse Full PDF: Rheumatoid Arthritis Diagnosis Test Market

The digital signature is as good as handwritten signature and provide more security. It’s a mathematical technique used to check the authenticity of a message, software, and a digital document. The primary aim of digital signature is to solve the problem of impersonation and tempering in digital communication. Digital signature contains each information of digital document so that an end user can easily find out source, identity, and status of an electronic document. Digital signature works on the principle of cryptography technology. Read the rest of this entry »

According to the latest market report published by Persistence Market Research, titled “North America Market Study on Speciality Solvents: Pharmaceutical and Personal Care Segment to Exhibit above Average Growth during the Forecast Period 2016 – 2022,” the North America specialty solvents market was valued at US$ 37.8 Bn in 2015 and is anticipated to expand at a CAGR of 4.5% from 2016 to 2022, to reach a market value of US$ 51.2 Bn by 2022. Read the rest of this entry »

Tag Cloud